Unfazed by critics over the legitimacy of its business model, Chinese healthcare crowdfunding site Shuidi raises $145 million from a star-studded list of investors.

Healthcare remains an attractive sector for investors. Chronic disease management platform 91health has just raised $100 million from a number of blue-chip names.

The Beijing-based investment bank brings a tightly priced dollar-denominated bond as it starts building out its own international debt financing platform.

CICC has agreed to buy China Investment Securities for $2.5 billion, showing its determination to keep expanding amid tough competition in China's brokerage market.

We explain how China's outstanding banks claimed FinanceAsia's awards, and why HSBC and Morgan Stanley were the top foreign players in the country.

With fortuitous timing, China's first joint venture investment bank posted one of the year's best first-day share price performances in Hong Kong.

The Chinese investment bank's final valuation range is a far cry from its initial billion-dollar ambitions.

China International Capital Corp has finally taken the first steps for its long-awaited $1 billion IPO in Hong Kong and could list as early as late September

Levin Zhu, son of former Chinese premier Zhu Rongji, tells the Boao Forum that finance still needs the human touch and that technology will not lead to its extinction.

Chinese investment banking giant adopts a more conservative valuation for its Hong Kong listing, but secures strong cornerstone commitments.